The NAE inhibitor pevonedistat interacts with the HDAC inhibitor belinostat to target AML cells by disrupting the DDRLiang Zhou, Steven Grant, Yun Leng et al.|Blood|2016Cited by 58
Development of a high throughput, molecular diagnostic assay for predicting telomerase activity in breast cancer cell lines and tissuesLynne W. Elmore, Shelby Holt, Ali Akalin et al.|Breast Cancer Research|2000Cited by 0